Induced Pluripotent Stem Cell Reprogramming via MicroRNA Delivery

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for producing induced pluripotent stem cells face challenges such as tumorigenesis and low efficiency, particularly due to the introduction of proto-oncogene c-Myc and inefficient gene integration methods.

Innovation Solution

A method involving the use of microRNAs as nuclear reprogramming factors to facilitate expression of genes like NANOG, SOX2, OCT3/4, KLF4, LIN28, and c-MYC without gene integration, which reduces tumorigenesis and enhances production efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If proto-oncogene c-Myc and other nuclear reprogramming factors are introduced into somatic cells to produce induced pluripotent stem cells, then pluripotent stem cell production is achieved, but tumorigenesis occurs due to cancer gene introduction and mutation induction

Engineering Contradiction:

Improvesafety of induced pluripotent stem cellsVSAvoidtumorigenesis

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes the harmful proto-oncogene c-Myc from the traditional reprogramming factor combination (OCT3/4, SOX2, c-MYC, KLF4), using only the safe combination of OCT3/4, SOX2, and KLF4 to induce pluripotent stem cells, thereby eliminating the risk of tumorigenesis associated with c-Myc introduction

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The invention converts the harmful effect of gene introduction by using an alternative approach: instead of introducing c-Myc which causes tumorigenesis, the patent utilizes the synergistic effect of the remaining three factors (OCT3/4, SOX2, KLF4) combined with enhanced culture conditions to achieve reprogramming without the harmful genetic modifications

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

2Productivity

If gene integration methods are used to introduce nuclear reprogramming factors into somatic cells, then induced pluripotent stem cells can be produced, but the production efficiency is low

Engineering Contradiction:

Improveinduction efficiency of induced pluripotent stem cellsVSAvoidtime required for induction

Core Design Contradiction:

ProductivityVSLoss of time

Solution Approach 1:

The invention applies preliminary action by pre-treating somatic cells with specific culture conditions and factors before introducing the reprogramming factors OCT3/4, SOX2, and KLF4, which prepares the cells to be more receptive to reprogramming and significantly enhances induction efficiency while reducing the time required

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The invention changes key parameters of the reprogramming process, including the combination of reprogramming factors (using OCT3/4, SOX2, KLF4 without c-Myc), culture medium composition, and incubation conditions, to optimize the induction efficiency and reduce the time required for generating induced pluripotent stem cells

Inventive Principle:

Principle #35Parameter changes

Data Source

PatentUS8852941B2Method for producing induced pluripotent stem cells

Publication Date: 2014.10.07 OSAKA UNIVERSITY

AI summary

A major object of the present invention is to provide a method for producing induced pluripotent stem cells with low tumorigenesis potential and high induction efficiency.The invention provides a method for producing induced pluripotent stem cells comprising the step of introducing one or more nucleic acids that facilitate expression of at least one gene selected from the group consisting of NANOG, SOX2, OCT3/4, KLF4, LIN28, and c-MYC into somatic cells.